HighTower Advisors LLC Buys 254,756 Shares of GE HealthCare Technologies Inc. $GEHC

HighTower Advisors LLC lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 184.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 392,674 shares of the company’s stock after acquiring an additional 254,756 shares during the quarter. HighTower Advisors LLC’s holdings in GE HealthCare Technologies were worth $29,490,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. True North Advisors LLC raised its stake in GE HealthCare Technologies by 2.0% during the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after buying an additional 139 shares during the last quarter. Klingman & Associates LLC increased its position in GE HealthCare Technologies by 4.0% during the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after acquiring an additional 139 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in GE HealthCare Technologies by 7.4% in the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock valued at $158,000 after acquiring an additional 148 shares during the period. Exchange Traded Concepts LLC boosted its position in GE HealthCare Technologies by 1.3% in the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock worth $863,000 after purchasing an additional 150 shares during the last quarter. Finally, Modera Wealth Management LLC grew its stake in shares of GE HealthCare Technologies by 3.5% during the 2nd quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock valued at $333,000 after purchasing an additional 152 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Citigroup increased their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Jefferies Financial Group increased their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. Finally, Bank of America raised their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $82.95 on Thursday. The stock has a 50-day moving average price of $82.32 and a 200 day moving average price of $77.84. The stock has a market capitalization of $37.80 billion, a P/E ratio of 18.19, a P/E/G ratio of 1.80 and a beta of 1.08. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $93.15. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same period in the previous year, the firm earned $1.45 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.